Busca avançada
Ano de início
Entree


N-Domain Isoform of Angiotensin I Converting Enzyme as a Marker of Hypertension: Populational Study

Texto completo
Autor(es):
Mostrar menos -
Maluf-Meiken, Leila C. V. ; Fernandes, Fernanda B. ; Aragao, Danielle S. ; Ronchi, Fernanda A. ; Andrade, Maria C. C. ; Franco, Maria C. ; Febba, Andreia C. S. ; Plavnik, Frida L. ; Krieger, Jose E. ; Mill, Jose G. ; Sesso, Ricardo C. C. ; Casarini, Dulce E.
Número total de Autores: 12
Tipo de documento: Artigo Científico
Fonte: INTERNATIONAL JOURNAL OF HYPERTENSION; v. 2012, p. 9-pg., 2012-01-01.
Resumo

The aim of this paper was to investigate the presence of the urinary 90 kDa N-domain ACE in a cohort of the population from Vitoria, Brazil, to verify its association with essential hypertension since this isoform could be a possible genetic marker of hypertension. Anthropometric, clinical, and laboratory parameters of the individuals were evaluated (n = 1150) and the blood pressure (BP) was measured. The study population was divided according to ACE isoforms in urine as follows: ACE 65/90/190, presence of three ACE isoforms (n = 795), ACE 90(+) (65/90) (n = 186), and ACE 90(-) (65/190) (n = 169) based on the presence (+) or absence (-) of the 90 kDa ACE isoform. The anthropometric parameters, lipid profile, serum levels of uric acid, glucose, and the systolic and diastolic BP were significantly greater in the ACE 90(+) compared with the ACE 90(-) and ACE 65/90/190 individuals. We found that 98% of individuals from the ACE 90(+) group and 38% from the ACE 65/90/190 group had hypertension, compared to only 1% hypertensive individuals in the ACE 90- group. There is a high presence of the 90 kDa N-domain ACE isoform (85%) in the studied population. The percentile of normotensive subjects with three isoforms was 62%. Our findings could contribute to the development of new efficient strategy to prevent and treat hypertension to avoid the development of cardiovascular disease. (AU)

Processo FAPESP: 02/13290-2 - Isoforma (90 kDa) da enzima conversora de Angiotensina I, potencial marcador genético de hipertensão: processamento, caracterização molecular e funcional, e segregação genética
Beneficiário:Dulce Elena Casarini
Modalidade de apoio: Auxílio à Pesquisa - Temático
Processo FAPESP: 10/51904-9 - Sistema renina angiotensina e calicreina cininas na hipertensão, obesidade, diabetes, desnutrição e sepses: mecanismos moleculares, celulares e fisiopatológicos
Beneficiário:Dulce Elena Casarini
Modalidade de apoio: Auxílio à Pesquisa - Temático